Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?

Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast Cancer Res (2010) 2.33

Histological and molecular types of breast cancer: is there a unifying taxonomy? Nat Rev Clin Oncol (2009) 1.91

Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer. Cancer Res (2011) 1.40

Predictive and prognostic molecular markers for cancer medicine. Ther Adv Med Oncol (2010) 1.18

Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study. BMC Cancer (2013) 1.05

Molecular profiling currently offers no more than tumour morphology and basic immunohistochemistry. Breast Cancer Res (2010) 1.05

Next-generation sequencing. Breast Cancer Res (2009) 0.94

Breast cancer subtypes and survival in chinese women with operable primary breast cancer. Chin J Cancer Res (2011) 0.85

Diversity of Breast Carcinoma: Histological Subtypes and Clinical Relevance. Clin Med Insights Pathol (2015) 0.83

Genomic markers for decision making: what is preventing us from using markers? Nat Rev Clin Oncol (2009) 0.82

Genetic characterization of breast cancer and implications for clinical management. J Cell Mol Med (2009) 0.81

Examining the pathogenesis of breast cancer using a novel agent-based model of mammary ductal epithelium dynamics. PLoS One (2013) 0.79

Transgelin: a potentially useful diagnostic marker differentially expressed in triple-negative and non-triple-negative breast cancers. Hum Pathol (2015) 0.79

Molecular Classification of Breast Carcinoma: From Traditional, Old-Fashioned Way to A New Age, and A New Way. J Breast Health (2013) (2015) 0.75

Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway. Oncotarget (2016) 0.75

Aberrant P-cadherin expression: is it associated with estrogen-independent growth in breast cancer? Pathol Res Pract (2002) 0.85

Caveolin-1 P132L mutation in human cancers: 1 CAVeat to be voiced. J Mol Diagn (2010) 0.76